For the most up to date information on COVID-19 please visit the Department of Health website. Learn more about how the AIHW is assisting the COVID-19 response and how our other work is affected. Our Covid-19 related resources page includes a list of some existing resources which may be useful when researching issues related to COVID-19.
Spending on chronic kidney disease rose by over a third between 2000-01 and 2004-05 and is expected to continue to rise, according to a report released today by the Australian Institute of Health and Welfare (AIHW).
Chronic kidney disease, or CKD, is a common and serious problem in Australia and its management can be resource intensive.
The report, Health care expenditure on chronic kidney disease 2004-05, shows that almost $900 million was spent on chronic kidney disease in 2004-05.
'The 33% rise outstripped the 19% rise in total health care expenditure over the same period,' said Ms Frances Green of the AIHW's Cardiovascular Disease, Diabetes and Kidney Unit.
People with CKD's most severe form, end-stage kidney disease, usually require dialysis or a kidney transplant to survive.
'Regular dialysis-usually three times a week-is the most common reason for hospitalisation in Australia, accounting for more than 10% of all admissions,' Ms Green said.
'And the number of dialysis patients is increasing each year. In 2000 there were around 6,400 people receiving dialysis but by 2007 there were nearly 10,000,' she said.
Around $760 million (almost 85% of total CKD expenditure) was due to dialysis and transplants, with dialysis alone accounting for more than $593 million.
Health care expenditure on chronic kidney disease 2004-05 is the first report of its kind on chronic kidney disease spending in Australia.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.